Form 4 for NHS Neuberger High Yield Strategies Fund Inc.
Accepted 2022-06-07 00:00:00 ET · period of report 2022-06-03 · accession 0001567619-22-012442 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IE | 2022-06-07 | 2022-06-03 | NHS | MetLife Investment Management, LLC | 10% | P - Purchase | $26,500,000.00 | +26.50M | 26.50M | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Floating Rate Senior Note, Series B Note, Due Sep. 18, 2023 | 2022-06-03 | P | A | 26,500,000 | $26,500,000.00 | 26,500,000 | I See Footnotes | — | — | (F1) This price reflects the aggregate principal amount of the Floating Rate Senior Note, Series B Note, due September 18, 2023 (the "Notes") purchased. (F2) These Notes are held directly by a client for whom the Reporting Person serves as investment manager. (F3) The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |